c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease - Test2 - elhamkhani - TriplyDB

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease

http://www.wikidata.org/entity/Q26770431

about

High quality, small molecule-activity datasets for kinase research Zinc Finger E-Box Binding Protein 2 (ZEB2) Suppress Apoptosis of Vascular Endothelial Cells Induced by High Glucose Through Mitogen-Activated Protein Kinases (MAPK) Pathway Activation Genistein protects against Aβ25-35 induced apoptosis of PC12 cells through JNK signaling and modulation of Bcl-2 family messengers.Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity.TNFSF15 suppresses VEGF production in endothelial cells by stimulating miR-29b expression via activation of JNK-GATA3 signals.Gankyrin as a potential therapeutic target for cancer.Functional Cooperation between KCa3.1 and TRPV4 Channels in Bronchial Smooth Muscle Cell Proliferation Associated with Chronic Asthma.Metformin Alleviated Aβ-Induced Apoptosis via the Suppression of JNK MAPK Signaling Pathway in Cultured Hippocampal Neurons Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists.Rho GTPases as therapeutic targets in Alzheimer's disease.JNK inhibitor alleviates apoptosis of fetal neural stem cells induced by emulsified isoflurane.Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy.Mechanism of the effect of saikosaponin on atherosclerosis in vitro is based on the MAPK signaling pathway.MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs.TGFβ as a therapeutic target in cystic fibrosis.From Mitochondrial Function to Neuroprotection-an Emerging Role for Methylene Blue.A Specific and Covalent JNK-1 Ligand Selected from an Encoded Self-Assembling Chemical Library.High mobility group box 1 (HMGB1): dual functions in the cochlear auditory neurons in response to stress?

P2860

Q28596330-4F608994-D840-42EE-A4C2-E535C30E4A00 Q33764076-45123B1C-1209-46CB-96C4-EF4C0CC74532 Q36248069-1A97A371-60AF-40DC-9786-9916DDFAD262 Q36767908-AB8E9D09-2856-4D11-98F5-8F8A67565D45 Q37322106-C28979DF-514F-46E6-8C7D-611D90209D58 Q37688387-F72CE44C-CB1B-490E-9463-4FBF20CBE214 Q39319386-8FDA369D-2DF3-48CC-8D34-91FEC1F93736 Q41836970-2C56EEA7-E63B-4C31-AD15-F363516A911A Q41971562-3AA616B0-7D84-43CE-834A-CA980D60DF77 Q46279808-E4BEED6D-3553-46B1-A12E-D5AC5997A139 Q47110501-AE0A991C-8634-4C3A-A406-BF2110FD9AE8 Q47121976-26FC8D49-CB13-4E25-9402-56EB2521E4C2 Q47222390-38242B44-1811-4447-BF49-B27BEC628235 Q47679870-AD073807-D866-4005-88E1-E5D1E300AAB4 Q47726182-DBFEA203-FF0B-49DD-8CC8-9A0A5FDEB52E Q47822059-9D58FA87-924B-4A2A-BA52-3402C77FF20C Q48004149-9BCCB644-EAB4-4375-9AD8-BD3431A269B5 Q48172577-F95038A1-D177-47CF-B2C0-5231C61FFC5F Q51430543-E4E89031-4D14-436A-A9D6-333707A49361

P2860

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease

http://www.wikidata.org/entity/Q26770431

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease

@ast

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease

@en

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease

@nl

type

label

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease

@ast

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease

@en

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease

@nl

prefLabel

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease

@ast

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease

@en

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease

@nl

P1433

Q26770431-4C770B6D-5F54-4988-BD6F-50327386440A

P1476

Q26770431-EDFDB090-0756-407D-A028-292E295A0369

P2093

Q26770431-8981EBEC-F14E-424C-A250-D3FE6C2FAB24

Q26770431-A5BEE5CC-45F5-4B60-8B79-F6CF1D9164AA

P2860

Q26770431-01A61783-6F3B-4DA7-9A6D-C6A02C1DC0C3

Q26770431-020519D9-7696-45EB-AA64-168B0361EBF4

Q26770431-0655AA60-24FE-404B-9CF5-A74110DFBB99

Q26770431-094793DB-8F6D-46AA-A770-699F4B7C90C5

Q26770431-0B7C9F54-724D-4877-9B5E-B3FDA974E2D6

Q26770431-0BDF2700-EA20-4692-833E-03A88F9B11DC

Q26770431-0D178609-321B-4945-BB17-8667C3FFB8D9

Q26770431-0DBDD4D0-6E87-4C6F-B64F-D222F218FE48

Q26770431-1037077B-3232-4211-B0BF-511207F98CD7

Q26770431-13CE65CD-45A9-4B7C-A020-46E2F8E17821

P304

Q26770431-7552C722-0FDA-4E8C-A8BE-ACB360DB1608

P31

Q26770431-F5D83691-B8CB-4D1F-9D1D-74C56078F0E0

P3181

Q26770431-CDF34064-F9D3-4A77-B818-0861BF63F5BE

P356

Q26770431-4B5A78AD-8CE2-4D88-BECF-FBC77D4BBFE6

P407

Q26770431-9A7E4B72-243A-40DD-A579-410C994F98C0

P478

Q26770431-AA699E5D-01E8-41D3-8340-2E944DCCF568

P50

Q26770431-89A459C1-9898-475C-8822-BCAC79805EC7

Q26770431-F145C31C-6349-4009-ABB7-25B6317FBFB3

P577

Q26770431-795D8D91-4A39-4251-8537-7F1CEB90B280

P5875

Q26770431-C0B0B0E4-6EFA-4AE1-AC20-8924FE53030D

P698

Q26770431-5F0336A4-745C-4F51-B437-E72AC67BBF9A

P921

Q26770431-9E1CB4B0-283E-4412-9E37-F8D5489E2327

P932

Q26770431-4A0D28EC-4BBD-41D2-953D-CA35702B307B

P3181

P356

FPHAR.2015.00321

P1433

Frontiers in Pharmacology

P1476

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease

@en

P2093

Ramon Yarza

http://www.w3.org/2001/XMLSchema#string

Silvia Vela

http://www.w3.org/2001/XMLSchema#string

P2860

Signal transduction by the JNK group of MAP kinases

Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease

AP-1 inhibitory peptides attenuate in vitro cortical neuronal cell death induced by kainic acid

Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene

A cytoplasmic inhibitor of the JNK signal transduction pathway

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway

The specificities of protein kinase inhibitors: an update

Inhibitors of c-Jun N-terminal kinases: JuNK no more?

Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3.

P304

321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

782744

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FPHAR.2015.00321

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Maria Javier Ramírez

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

290478036

http://www.w3.org/2001/XMLSchema#string

P698

26793112

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4709475

http://www.w3.org/2001/XMLSchema#string